Free tool
FAERS Monitor: Neoprofen
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021903 or its brand name (Neoprofen, Ibuprofen Lysine). Reports on generic versions are filed under their own applications.
Reports
569
Serious
553
97% of reports
Hospitalization
135
Death reported
94
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- bronchopulmonary dysplasia113
- intraventricular haemorrhage34
- necrotising colitis30
- gastrointestinal perforation29
- completed suicide27
- anaemia25
- hyponatraemia25
- intestinal perforation25
- urine output decreased23
- death20
- pulmonary haemorrhage20
- posthaemorrhagic hydrocephalus19
- retinopathy of prematurity18
- dizziness17
- pulmonary hypertension17
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 28 |
| 2007 | 37 |
| 2008 | 45 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 150 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 23 |
| 2016 | 24 |
| 2017 | 3 |
| 2018 | 9 |
| 2019 | 39 |
| 2020 | 28 |
| 2021 | 42 |
| 2022 | 26 |
| 2023 | 18 |
| 2024 | 55 |
| 2025 | 16 |
| 2026 | 7 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,590 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| posthaemorrhagic hydrocephalusSignal | 19 | 18026.1 | 10482.0 | 218,313 |
| bronchopulmonary dysplasiaSignal | 113 | 6042.1 | 5041.2 | 581,561 |
| retinopathy of prematuritySignal | 18 | 1242.6 | 782.5 | 20,421 |
| necrotising colitisSignal | 30 | 896.6 | 630.1 | 25,338 |
| intraventricular haemorrhageSignal | 34 | 512.2 | 368.9 | 16,612 |
| gastrointestinal perforationSignal | 29 | 259.6 | 181.9 | 7,166 |
| urine output decreasedSignal | 23 | 97.5 | 65.3 | 2,097 |
| pulmonary haemorrhageSignal | 20 | 94.7 | 61.6 | 1,758 |
| intestinal perforationSignal | 25 | 82.5 | 56.2 | 1,929 |
| pulmonary hypertensionSignal | 17 | 30.2 | 18.9 | 451 |
| hyponatraemiaSignal | 25 | 16.4 | 11.2 | 347 |
| completed suicideSignal | 27 | 12.0 | 8.3 | 262 |
| anaemiaSignal | 25 | 4.8 | 3.3 | 73 |
| dizziness | 17 | 1.3 | 0.8 | 1 |
| death | 20 | 0.9 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.